Citation Impact
Citing Papers
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Three-Dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size
2013 Standout
Host Response to Implanted Porcine-Derived Biologic Materials in a Primate Model of Abdominal Wall Repair
2008
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Differential immune responses to α-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation
2000
Modifying the sugar icing on the transplantation cake
2016
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
The Stem Region of the Sulfotransferase GlcNAc6ST-1 Is a Determinant of Substrate Specificity
2004 StandoutNobel
DISCORDANT ORGAN XENOTRANSPLANTATION IN PRIMATES
1998
Exploring neoglycoprotein assembly through native chemical ligation using neoglycopeptide thioesters prepared via N→S acyl transfer
2010 StandoutNobel
Synthetic glycobiology: exploits in the Golgi compartment
2006 StandoutNobel
Xenograft rejection: IgG, complement and NK cells team up to activate and destroy the endothelium
2004
Xenogeneic extracellular matrix as a scaffold for tissue reconstruction
2004
Regulating Cell Surface Glycosylation by Small Molecule Control of Enzyme Localization
2003 StandoutNobel
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Expression of -gal epitopes on HeLa cells transduced with adenovirus containing 1,3galactosyltransferase cDNA
2002
In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the α1,3galactosyltransferase gene
2005
ABO blood group and related antigens, natural antibodies and transplantation
2006
Metabolic labeling of glycoproteins with chemical tags through unnatural sialic acid biosynthesis
2000 StandoutNobel
Molecular Basis of Evolutionary Loss of the α1,3-Galactosyltransferase Gene in Higher Primates
2002
Functions of natural killer cells
2008 Standout
Biological roles of glycans
2016 Standout
Oocyte Galα1,3Gal Epitopes Implicated in Sperm Adhesion to the Zona Pellucida Glycoprotein ZP3 Are Not Required for Fertilization in the Mouse
1995
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Protein-bound carbohydrates on cell-surface as targets of recognition: An Odyssey in understanding them
2000
Xenotransplantation: Role of natural immunity
2008
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
Metabolic Delivery of Ketone Groups to Sialic Acid Residues
1998 StandoutNobel
Complement inhibitory therapeutics and xenotransplantation
1995
Diabetes and Atherosclerosis
2002 Standout
Non-HLA-Type Endothelial Cell Reactive Alloantibodies in Pre-Transplant Sera of Kidney Recipients Trigger Apoptosis
2003
GLYCAM06: A generalizable biomolecular force field. Carbohydrates
2007 Standout
The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: A carbohydrate of unique evolution and clinical relevance
2007
Porcine α1,3-galactosyltransferase: tissue-specific and regulated expression of splicing isoforms
1997
HLA association of amoxicillin-clavulanate–induced hepatitis
1999
The Cytoplasmic Tail of α1,3-Galactosyltransferase Inhibits Golgi Localization of the Full-length Enzyme
2002
THE ??-1,3-GALACTOSYLTRANSFERASE KNOCKOUT MOUSE
1996
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis
1995
Directing Flux in Glycan Biosynthetic Pathways with a Small Molecule Switch
2004 StandoutNobel
Antibiotic-associated acute vanishing bile duct syndrome: A pattern associated with severe, prolonged, intrahepatic cholestasis
1994
Autologous tumor vaccines processed to express ?-gal epitopes: a practical approach to immunotherapy in cancer
2004
Chemical Approaches To Perturb, Profile, and Perceive Glycans
2009 StandoutNobel
Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database
2016
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents
1998 StandoutNobel
The Xenograft Antigen Bound to Griffonia simplicifolia Lectin 1-B4
2002
Golgi Localization of Carbohydrate Sulfotransferases Is a Determinant of L-selectin Ligand Biosynthesis
2003 StandoutNobel
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Infection of human cells by an endogenous retrovirus of pigs
1997 Standout
Switching Amino-terminal Cytoplasmic Domains of α(1,2)Fucosyltransferase and α(1,3)Galactosyltransferase Alters the Expression of H Substance and Galα(1,3)Gal
1996
Sensitization of cells and retroviruses to human serum by (αl-3) galactosyltransferase
1996 Nature
Inflammatory bowel disease: A descriptive study of 716 local Chilean patients
2016
Decellularization of tissues and organs
2006 Standout
Potential Application of Neonatal Porcine Islets as Treatment for Type 1 Diabetes: A Review
1999
Small Molecule Inhibitors of Mucin-Type O-Linked Glycosylation from a Uridine-Based Library
2004 StandoutNobel
Conditional Glycosylation in Eukaryotic Cells Using a Biocompatible Chemical Inducer of Dimerization
2008 StandoutNobel
Selective Tumor Cell Targeting Using Low-Affinity, Multivalent Interactions
2007
A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.
1995
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
2001 Standout
The future of cloning
1999 StandoutNatureNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Incisional ventral hernias: Review of the literature and recommendations regarding the grading and technique of repair
2010 Standout
New Directions in Glycoprotein Engineering
2000 StandoutNobel
Proteomics, Metabolomics, and Immunomics on Microparticles Derived From Human Atherosclerotic Plaques
2009
Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.
1994
Characteristics of protein–carbohydrate interactions as a basis for developing novel carbohydrate‐based antirejection therapies
2005
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Augmentin‐induced jaundice with a fatal outcome
1992
Functionally important glycosyltransferase gain and loss during catarrhine primate emergence
2006
Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase.
1996
XENOGENEIC TRANSPLANTATION
1998
Expression of the human α:1,2‐fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum‐mediated cytolysis
1999
Production of α-1,3-Galactosyltransferase Knockout Pigs by Nuclear Transfer Cloning
2002 StandoutScience
Preformed and elicited antibodies to pig antigens in nonhuman primates and humans
2001
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Expeditious Chemoenzymatic Synthesis of Homogeneous N-Glycoproteins Carrying Defined Oligosaccharide Ligands
2008
Chemical and Biological Strategies for Engineering Cell Surface Glycosylation
2001 StandoutNobel
Polymerized Liposome Assemblies: Bifunctional Macromolecular Selectin Inhibitors Mimicking Physiological Selectin Ligands
2001 StandoutNobel
Signal Transduction through MAP Kinase Cascades
1998 Standout
The Vascular Endothelium and Human Diseases
2013 Standout
The α‐gal epitope and the anti‐Gal antibody in xenotransplantation and in cancer immunotherapy
2005
Works of Paul Dabkowski being referenced
Distribution of the major xenoantigen (gal(α1–3)gal) for pig to human xenografts
1994
Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis
2015
Prospective population‐based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity
2015
Augmentin‐induced jaundice
1991
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.
1993
Characterization of cDNA clones for porcine α(l,3)galactosyl transferase: The enzyme generating the Galα(l,3)Gal epitope
1994